Analyst Rating Changes — Upgrades, Downgrades & Price Targets

52154 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.

Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.

All ↑ Upgrades ↓ Downgrades ◎ Price Targets

Latest Rating Changes

When	Stock	Change	Firm	Analyst	Rating	Price Target
Aug 13 00:18 UTC	OCDO Ocado Group	◎ Target	JPMorgan Chase & Co.	firm only	Overweight	GBX 245→ GBX 290+18.4%
Aug 13 00:18 UTC	NVRI Enviri	◎ Target	BMO Capital Markets	Devin Dodge ★★☆☆☆ #2267	Market Perform	$21.00→ $24.00+14.3%
Aug 13 00:18 UTC	NTRA Natera	◎ Target	Stephens	Mason Carrico ★★★☆☆ #1311	Overweight	$305.00→ $350.00+14.8%
Aug 13 00:18 UTC	NTRA Natera	◎ Target	Guggenheim	Subbu Nambi ★★★★☆ #789	Buy	$290.00→ $360.00+24.1%
Aug 13 00:18 UTC	NTRA Natera	◎ Target	Piper Sandler	David Westenberg ★★★☆☆ #1052	Overweight	$249.00→ $363.50+46.0%
Aug 13 00:18 UTC	NGNE Neurogene	◎ Target	HC Wainwright	Mitchell S. Kapoor not yet tracked	Buy	$70.00→ $65.00-7.1%
Aug 13 00:18 UTC	NGNE Neurogene	◎ Target	Canaccord Genuity Group	Whitney Ijem ★★★☆☆ #2206	Buy	$180.00→ $166.00-7.8%
Aug 13 00:18 UTC	NGNE Neurogene	◎ Target	Guggenheim	Debjit Chattopadhyay ★☆☆☆☆ #3190	Buy	$69.00→ $81.00+17.4%
Aug 13 00:18 UTC	NFI NFI Group	◎ Target	Scotiabank	firm only	Sec→ r Outperform	C$27.00→ C$28.50+5.6%
Aug 13 00:18 UTC	NEXN Nexxen International	◎ Target	BTIG Research	Tyler DiMatteo ★★★☆☆ #1192	Buy	$10.00→ $13.00+30.0%
Aug 13 00:18 UTC	NEXN Nexxen International	◎ Target	Needham & Company LLC	Laura Martin ★★★☆☆ #2068	Buy	$10.50→ $13.00+23.8%
Aug 13 00:18 UTC	NEO Neo Performance Materials	◎ Target	Stifel Nicolaus	firm only	Buy	C$49.00→ C$55.00+12.2%
Aug 13 00:18 UTC	NEM Newmont	◎ Target	Scotiabank	Tanya Jakusconek ★★☆☆☆ #2469	Outperform	$147.00→ $149.00+1.4%
Aug 13 00:18 UTC	NEM Newmont	◎ Target	Scotiabank	Tanya Jakusconek ★★☆☆☆ #2469	Sec→ r Outperform	$147.00→ $149.00+1.4%
Aug 13 00:18 UTC	NEM Newmont	◎ Target	TD	firm only	Buy	$127.00→ $133.00+4.7%
Aug 13 00:18 UTC	NA National Bank of Canada	◎ Target	TD	firm only	Hold	C$202.00→ C$227.00+12.4%
Aug 13 00:18 UTC	NA National Bank of Canada	◎ Target	Raymond James Financial	firm only	Market Perform	C$203.00→ C$226.50+11.6%
Aug 13 00:18 UTC	MTZ MasTec	◎ Target	The Goldman Sachs Group	Ati Modak not yet tracked	Buy	$508.00→ $409.00-19.5%
Aug 13 00:18 UTC	MSFT Microsoft	◎ Target	Wells Fargo & Company	Michael Turrin ★★★☆☆ #1682	Overweight	$650.00→ $700.00+7.7%
Aug 13 00:18 UTC	MPLX Mplx	◎ Target	Morgan Stanley	Robert Kad ★★★☆☆ #1435	Equal Weight	$60.00→ $66.00+10.0%
Aug 13 00:18 UTC	MOBI Mobia Medical	◎ Target	JPMorgan Chase & Co.	Robbie Marcus ★★★☆☆ #1132	Overweight	$15.00→ $17.00+13.3%
Aug 13 00:18 UTC	MNPR Monopar Therapeutics	◎ Target	BTIG Research	Jeet Mukherjee ★★★☆☆ #2058	Buy	$117.00→ $133.00+13.7%
Aug 13 00:18 UTC	MLCO Melco Resorts & Entertainment	◎ Target	Susquehanna	Joseph Stauff ★★☆☆☆ #2644	Positive	$12.00→ $8.00-33.3%
Aug 13 00:18 UTC	MIDD Middleby	◎ Target	JPMorgan Chase & Co.	Tami Zakaria ★★★☆☆ #1354	Neutral	$151.00→ $141.00-6.6%
Aug 13 00:18 UTC	MFIC MidCap Financial Investment	◎ Target	Royal Bank Of Canada	Kenneth S. Lee not yet tracked	Sec→ r Perform	$11.00→ $10.00-9.1%
Aug 13 00:18 UTC	MDLN Medline	◎ Target	JPMorgan Chase & Co.	Lisa Gill ★★★☆☆ #1908	Overweight	$53.00→ $46.00-13.2%
Aug 13 00:18 UTC	MDB MongoDB	◎ Target	Oppenheimer	Ittai Kidron ★★★★★ #324	Outperform	$410.00→ $475.00+15.9%
Aug 13 00:18 UTC	MAU Montage Gold	◎ Target	Stifel Nicolaus	firm only	Buy	C$18.00→ C$21.00+16.7%
Aug 13 00:18 UTC	MAU Montage Gold	◎ Target	Scotiabank	firm only	Sec→ r Outperform	C$19.00→ C$20.00+5.3%
Aug 13 00:18 UTC	MAU Montage Gold	◎ Target	ATB Cormark Capital Markets	firm only	Outperform	C$19.00→ C$22.00+15.8%
Aug 13 00:18 UTC	MASS 908 Devices	◎ Target	Stifel Nicolaus	Daniel Arias ★★★★☆ #777	Buy	$10.00→ $12.00+20.0%
Aug 13 00:18 UTC	MASS 908 Devices	◎ Target	Roth Capital	Max Masucci not yet tracked	Buy	$11.00→ $13.00+18.2%
Aug 13 00:18 UTC	MAA Mid-America Apartment Communities	◎ Target	Morgan Stanley	Adam Kramer ★★★☆☆ #1315	Overweight	$155.00→ $147.00-5.2%
Aug 13 00:18 UTC	LQDA Liquidia	◎ Target	BTIG Research	Julian Harrison ★★☆☆☆ #2643	Buy	$109.00→ $111.00+1.8%
Aug 13 00:18 UTC	LQDA Liquidia	◎ Target	Needham & Company LLC	Serge Belanger ★★☆☆☆ #2399	Buy	$70.00→ $110.00+57.1%
Aug 13 00:18 UTC	LOW Lowe's Companies	◎ Target	Royal Bank Of Canada	Steven Shemesh ★★★☆☆ #1242	Sec→ r Perform	$232.00→ $231.00-0.4%
Aug 13 00:18 UTC	LITE Lumentum	◎ Target	TD Cowen	Sean O'Loughlin ★★★☆☆ #1992	Hold	$800.00→ $820.00+2.5%
Aug 13 00:18 UTC	LITE Lumentum	◎ Target	JPMorgan Chase & Co.	Joseph Cardoso ★★★★☆ #837	Overweight	$1,165.00→ $1,280.00+9.9%
Aug 13 00:18 UTC	LITE Lumentum	◎ Target	Bank of America	Vivek Arya ★★☆☆☆ #2698	Neutral	$1,100.00→ $1,000.00-9.1%
Aug 13 00:18 UTC	LITE Lumentum	◎ Target	Morgan Stanley	Meta Marshall ★★★☆☆ #1903	Equal Weight	$900.00→ $1,000.00+11.1%
Aug 13 00:18 UTC	LITE Lumentum	◎ Target	Mizuho	Vijay Rakesh ★★★☆☆ #2191	Outperform	$1,100.00→ $1,140.00+3.6%
Aug 13 00:18 UTC	LENZ LENZ Therapeutics	◎ Target	Piper Sandler	Biren Amin ★★☆☆☆ #2276	Neutral	$12.00→ $7.00-41.7%
Aug 13 00:18 UTC	LEGN Legend Biotech	◎ Target	Morgan Stanley	Matthew Harrison not yet tracked	Overweight	$48.00→ $49.00+2.1%
Aug 13 00:18 UTC	LEGN Legend Biotech	◎ Target	Royal Bank Of Canada	Leonid Timashev ★★★☆☆ #1572	Outperform	$59.00→ $58.00-1.7%
Aug 13 00:18 UTC	LEGN Legend Biotech	◎ Target	TD Cowen	Yaron Werber ★★☆☆☆ #2303	Hold	$29.00→ $24.00-17.2%
Aug 13 00:18 UTC	LEGN Legend Biotech	◎ Target	Barclays	Etzer Darout ★★★★☆ #586	Overweight	$80.00→ $78.00-2.5%
Aug 13 00:18 UTC	LEG Leggett & Platt	◎ Target	Piper Sandler	Peter Keith ★★★☆☆ #1332	Neutral	$12.00→ $10.00-16.7%
Aug 13 00:18 UTC	LDOS Leidos	◎ Target	The Goldman Sachs Group	Gavin Parsons ★★★☆☆ #2026	Neutral	$152.00→ $132.00-13.2%
Aug 13 00:18 UTC	LBRX LB Pharmaceuticals	◎ Target	BMO Capital Markets	Malcolm Hoffman not yet tracked	Outperform	$46.00→ $54.00+17.4%
Aug 13 00:18 UTC	LAR Lithium Americas (Argentina)	◎ Target	Scotiabank	Ben Isaacson ★★☆☆☆ #2519	Sec→ r Outperform	$10.00→ $9.50-5.0%

🔒 38 more rating changes on this page — plus filtering by our own analyst accuracy.

A free account unlocks the full daily feed.

Frequently Asked Questions

What are analyst rating changes?

An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.

How is this feed different from other rating trackers?

Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.

How often is the rating-changes feed updated?

The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.

Do analyst upgrades and price-target increases mean I should buy?

No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.

Analyst Rating Changes — Upgrades, Downgrades & Price Targets

Latest Rating Changes

Frequently Asked Questions

Welcome to 13Foresight!